[SciVision Biotech Inc.] 2026 Q1 EPS 0.29
NQ Score
0/100
N1 Content Completeness
85
Key facts
- [SciVision Biotech Inc.] 2026 Q1 EPS 0.29
- SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
- Source: TWSE
- Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
- Citation
- [SciVision Biotech Inc.] 2026 Q1 EPS 0.29 (Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
AI Analysis
Frequently Asked Questions
- Q: What are the key facts in this article?
- A: SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
- Q: What is the direct answer?
- A: SciVision Biotech Inc. reported its Q1 2026 financial results with an EPS of 0.29, revenue of 205 million NTD, and a net profit of 22 million NTD.
- Q: What is the source and date?
- A: Source: https://openapi.twse.com.tw/financial/twse-fin-1786-2026Q1 | Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)